These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 30579445)

  • 1. Invited commentary.
    Li C; Carroll BJ; Schermerhorn ML
    J Vasc Surg; 2019 Jan; 69(1):199-200. PubMed ID: 30579445
    [No Abstract]   [Full Text] [Related]  

  • 2. [The heart of women is not like it used to be, either. Cardiovascular risk factors and their treatment. Interview with Dr. Gábor Simonyi by Anna Radnai].
    Simonyi G
    Orv Hetil; 2013 Mar; 154(10):399-400. PubMed ID: 23461983
    [No Abstract]   [Full Text] [Related]  

  • 3. Highlights of the 56th annual scientific session of the American College of Cardiology.
    Rabasseda X
    Timely Top Med Cardiovasc Dis; 2007 Apr; 11():E12. PubMed ID: 18297150
    [No Abstract]   [Full Text] [Related]  

  • 4. Metabolic syndrome: navigating a danger zone of heart risk factors.
    Health After 50 Sci Am Consum Health; 2015 Sep; 27(8):1-2. PubMed ID: 26685336
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management.
    Grundy SM; Hansen B; Smith SC; Cleeman JI; Kahn RA; ; ;
    Circulation; 2004 Feb; 109(4):551-6. PubMed ID: 14757684
    [No Abstract]   [Full Text] [Related]  

  • 6. Altered Risk for Cardiovascular Events With Changes in the Metabolic Syndrome Status.
    Finucane TE
    Ann Intern Med; 2020 May; 172(10):707. PubMed ID: 32422108
    [No Abstract]   [Full Text] [Related]  

  • 7. Altered Risk for Cardiovascular Events With Changes in the Metabolic Syndrome Status.
    Park S; Han K; Kim DK
    Ann Intern Med; 2020 May; 172(10):707-708. PubMed ID: 32422106
    [No Abstract]   [Full Text] [Related]  

  • 8. Invited commentary.
    Krukenkamp I
    Ann Thorac Surg; 2007 Jun; 83(6):2073. PubMed ID: 17532399
    [No Abstract]   [Full Text] [Related]  

  • 9. Comment on “Metabolic syndrome is associated with cardiovascular events in haemodialysis”.
    Esteve-Simo V; Pou-Potau M; Fulquet-Nicolas M; Ramírez-de Arellano M
    Nefrologia; 2014; 34(5):675-6. PubMed ID: 25259821
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum granzyme-B, insulin resistance, metabolic syndrome and cardiovascular risk: statistical validity for risk assessment.
    Kawada T
    Eur J Obstet Gynecol Reprod Biol; 2016 Sep; 204():122. PubMed ID: 27498306
    [No Abstract]   [Full Text] [Related]  

  • 11. The pharmacological management of metabolic syndrome.
    Rask Larsen J; Dima L; Correll CU; Manu P
    Expert Rev Clin Pharmacol; 2018 Apr; 11(4):397-410. PubMed ID: 29345505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Perspectives for the Importance of Cardiometabolic Risk Factors.
    Intorp HW; Hussmann S
    Dtsch Arztebl Int; 2017 Mar; 114(12):212. PubMed ID: 28407845
    [No Abstract]   [Full Text] [Related]  

  • 13. Metabolic Syndrome Among Leukemia Survivors: Still Delineating the Risk.
    Saultier P; Oudin C; Michel G
    Metab Syndr Relat Disord; 2017 Aug; 15(6):263-265. PubMed ID: 28557564
    [No Abstract]   [Full Text] [Related]  

  • 14. Heart rate variability and the metabolic syndrome: a systematic review of the literature.
    Stuckey MI; Tulppo MP; Kiviniemi AM; Petrella RJ
    Diabetes Metab Res Rev; 2014 Nov; 30(8):784-93. PubMed ID: 24816921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High incidence of metabolic syndrome further increases cardiovascular risk in patients with type 2 diabetes. Implications for everyday practice.
    Athyros VG; Mikhailidis DP
    J Diabetes Complications; 2016; 30(1):9-11. PubMed ID: 26275865
    [No Abstract]   [Full Text] [Related]  

  • 16. Metabolic Syndrome and Cardiovascular Risk in People Treated with Long-Acting Injectable Antipsychotics.
    Sanchez-Martinez V; Romero-Rubio D; Abad-Perez MJ; Descalzo-Cabades MA; Alonso-Gutierrez S; Salazar-Fraile J; Montagud V; Facila L
    Endocr Metab Immune Disord Drug Targets; 2018; 18(4):379-387. PubMed ID: 29165095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic syndrome, the risk of cardiovascular disease, physical activity and childhood cancer survivors (Commentry on Slater et al.).
    Goddard KJ
    Pediatr Blood Cancer; 2015 Feb; 62(2):188-189. PubMed ID: 25407382
    [No Abstract]   [Full Text] [Related]  

  • 18. Uterine fibroids and cardiovascular risk.
    Uimari O; Auvinen J; Jokelainen J; Puukka K; Ruokonen A; Järvelin MR; Piltonen T; Keinänen-Kiukaanniemi S; Zondervan K; Järvelä I; Ryynänen M; Martikainen H
    Hum Reprod; 2016 Dec; 31(12):2689-2703. PubMed ID: 27733532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated estimated arterial age is associated with metabolic syndrome and low-grade inflammation.
    Greve SV; Blicher MK; Kruger R; Sehestedt T; Gram-Kampmann E; Rasmussen S; Vishram JK; Boutouyrie P; Laurent S; Olsen MH
    J Hypertens; 2016 Dec; 34(12):2410-2417. PubMed ID: 27512974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. European Heart Systemic Coronary Risk Evaluation may underestimate cardiovascular risk after assessing cardiovascular disease with carotid ultrasound in hidradenitis suppurativa.
    González I; Pascual JC; Corona D; Hispán P; Betlloch I
    Br J Dermatol; 2018 Jan; 178(1):e22-e23. PubMed ID: 28667744
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.